Advancing Breast Cancer Screening With A Non-invasive Blood Test
About BCAL Diagnostics
BCAL Diagnostics (ASX: BDX) is an Australian and US-based biotechnology company dedicated to advancing early and accurate breast cancer detection.
Our innovative, non-invasive blood test is designed to complement existing screening methods, empowering women and their clinicians with greater confidence in diagnostic outcomes. By improving screening accuracy and reducing unnecessary follow-ups, we aim to enable timely intervention and better health outcomes for women worldwide.
The Board of BCAL Diagnostics is committed to transparency, integrity, and accountability, ensuring our governance framework supports long-term growth and sustainability.
A strong, values-based governance structure is fundamental to our company, guiding ethical decision-making and responsible business practices. We align with best practice principles and the ASX Corporate Governance Council’s recommendations to uphold these standards.
For more details, download our key policies below.
Join Our Team in Transforming Breast Cancer Detection
We invite you to take the next step:
- Discover how BCAL’s blood test is changing the future of breast cancer detection - Discuss our test with your doctor to see if it's right for you - Support our mission by exploring investment opportunities with BCAL Diagnostics (ASX: BDX)
Contact our team today—we’re here to answer your questions, provide more information, or connect you with the right resources.
Contact Us
